SamSearch Platform
AI-powered intelligence for the right opportunities, the right leads, and the right time.
Contract Category
30 federal contract opportunities classified as Cancer Treatment.
DEPARTMENT OF HEALTH AND HUMAN SERVICES
AI Summary
The Department of Health and Human Services seeks a contractor for the synthesis of two specific chemical compounds for a Janus kinase 2 (JAK2) enzyme project. This non-competitive opportunity requires the compounds to be delivered at 95% purity within two months of order approval. The work will support brain cancer re…
MD
DEPARTMENT OF VETERANS AFFAIRS
AI Summary
The Department of Veterans Affairs is seeking qualified contractors to provide the radiopharmaceutical agent Pluvicto for the St. Louis VAMC. This sources sought notice is for market research and does not constitute a solicitation. Interested parties must submit their qualifications by June 18, 2025, to be considered f…
KS
AI Summary
The National Institutes of Health is conducting a clinical trial to evaluate the efficacy and safety of LMP744 in patients with recurrent glioblastoma. This study aims to assess progression-free survival and correlate molecular profiles with clinical outcomes. The trial will involve monitoring 40 patients to provide cr…
MD
AI Summary
The Department of Veterans Affairs intends to issue a sole-source contract to Boston Scientific for TheraSphere Y-90 Glass Microspheres, essential for targeted radiation therapy at the Jesse Brown VA Medical Center. Services will be provided from April 1, 2026, to March 31, 2027. Interested parties may submit capabilit…
WI
AI Summary
The Department of Veterans Affairs intends to issue a sole-source contract to Boston Scientific for TheraSphere Y-90 Glass Microspheres, essential for targeted radiation therapy at the Ralph H. Johnson VA Medical Center. Services will span from May 1, 2025, to April 30, 2027, with two optional periods. Interested parti…
GA
AI Summary
The Department of Veterans Affairs intends to negotiate a sole source contract for the FDA approved radioactive therapy drug Lu177 PLUVICTO and Lu177 LUTATHERA. This unique product is essential for prostate cancer treatment and will be supplied by Novartis. The contract will be a one-year firm fixed price, and no compe…
OH
DEPARTMENT OF VETERANS AFFAIRS
AI Summary
The Department of Veterans Affairs intends to award a sole source task order to Progenics Pharmaceuticals, Inc. for PYLARIFY® (piflufolastat F 18) Injections. This procurement is for unit dose syringes of F-18 Piflufolastat for PET imaging, essential for diagnosing various pathologies. Interested parties may express th…
CO
DEPARTMENT OF VETERANS AFFAIRS
AI Summary
The Department of Veterans Affairs intends to award a sole source contract to Cardinal Health for the procurement of XOFIGO® (Radium-223 dichloride). This procurement is based on a price agreement set by Bayer Healthcare, confirming Cardinal Health as the sole source in the U.S. Interested parties may submit capability…
TX
AI Summary
The Department of Veterans Affairs is seeking sources for F18 PSMA PYLARIFY radiopharmaceuticals for the Baltimore VA Medical Center. This sources sought notice aims to gather information on potential suppliers capable of providing these medical supplies, which are essential for PET imaging in prostate cancer diagnosis…
MD
AI Summary
The Miami VA Medical Center intends to award a sole source contract to Sirtex Medical, Inc. for SIR-Spheres Y-90 resin microspheres, an FDA-approved treatment for liver cancer. This notice is not a request for competitive proposals, and no solicitation documents are available. Interested businesses may submit written n…
FL
AI Summary
The Miami VA Medical Center intends to award a sole source contract to Boston Scientific for TheraSphere Y-90 Glass Microspheres, an FDA-approved treatment for liver cancer. This opportunity is not open for competitive proposals, and no solicitation documents are available. Interested businesses may submit written noti…
FL
DEPARTMENT OF VETERANS AFFAIRS
AI Summary
The VA Phoenix Healthcare System seeks a sole source contract for Pluvicto, a radiopharmaceutical therapy for prostate cancer. Interested parties must provide a capability statement and relevant information by October 31, 2025. This notice is not a request for competitive quotes, and the government may award a contract…
AZ
DEPARTMENT OF VETERANS AFFAIRS
AI Summary
The Department of Veterans Affairs intends to award a sole source contract for 9 units of Pluvicto, a radiopharmaceutical therapy for prostate cancer, to Novartis Pharmaceuticals Corporation. Interested parties must provide a capability statement and relevant information by October 20, 2025. This opportunity is not a r…
NY
AI Summary
The Department of Veterans Affairs intends to negotiate solely with Boston Scientific for TheraSphere Y-90 doses, a radiopharmaceutical used to treat liver cancer. This opportunity is a Source Sought notice under FAR 13.5, and responses are due by October 27, 2025. Interested parties may submit their capabilities for c…
OH
AI Summary
The Department of Veterans Affairs is seeking to procure Pylarify, a radiopharmaceutical used for prostate cancer treatment, from Progenics Pharmaceuticals, Inc. This acquisition is justified as a sole source due to the unique nature of the drug and its FDA approval. The estimated value is $1,082,616 per year, with a t…
OH
AI Summary
The Department of Veterans Affairs is seeking a sole source procurement of Lutetium Lu177 Vipivotide Tetraxetan (PLUVICTO) from Novartis Pharmaceuticals Corporation for the treatment of metastatic castrate resistant prostate cancer. This acquisition is justified under FAR 8.405-6 due to the unique nature of the product…
OH
AI Summary
The Department of Veterans Affairs intends to award a sole source contract to Novartis Pharmaceuticals for the purchase of Pluvicto, a specialized radiopharmaceutical for treating prostate cancer. This notice is not a request for competitive proposals, but interested parties may submit evidence of their capability by S…
CA
AI Summary
The Department of the Army intends to award a sole source contract to Boston Scientific for Yttrium 90 microspheres, a liver cancer therapy. This product is FDA approved and will be used at Brooke Army Medical Center. The award is expected by September 30, 2025.
TX
AI Summary
The Department of Veterans Affairs intends to award a sole source contract for Pylarify Injection (Piflufolastat F 18) to Progenics Pharmaceuticals, Inc. This highly specialized radiopharmaceutical is used for PET imaging in prostate cancer patients. Interested parties may submit evidence of their capability by 5:00 PM…
WI
AI Summary
The Department of Veterans Affairs intends to award a sole source contract to Novartis Pharmaceuticals for the purchase of Pluvicto, a specialized radiopharmaceutical for treating metastatic castration-resistant prostate cancer. This notice is not a request for proposals, and interested parties must provide evidence of…
WI
Common questions about finding and winning Cancer Treatment government contracts.